Targeting HSPB1 inhibits tumor growth and abrogates Treg-mediated tumor immunosuppression

International Immunopharmacology 2026 Open access

Read full text

Authors: Qi Hu, Yang Lu, Xiaolan Zhong, Peng Huang, Lisheng Zheng, Bing-Hua Jiang, Wanglin Li, Song Guo Zheng

DOI: 10.1016/j.intimp.2026.116333

Cited by: 0

References: 46

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology Immune cells in cancer

References 46